Your LCRF Fall e-news is here!
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌       


Fall 2023

Science News | Get Involved | Patient Journey

Can you believe we're moving into the final months of 2023? All the developments taking place at LCRF and the greater lung cancer community give us hope for the future. And it's all because of you! When LCRF announces its 2023 class of research grantees in coming weeks, you can be proud of the work you're supporting. Keep an eye on your email, social media, and the LCRF website for details.

Meet Colleen Conner Ziegler
First patient in treatment to serve as LCRF chair
Ms. Conner Ziegler, who was named LCRF Board Chair in September, was diagnosed with stage 4 ALK positive non-small cell lung cancer in 2015. She previously served LCRF as a member of its board, Scientific Advisory Board (SAB) and executive committee; and as a patient volunteer Research Advocate.

Honored at 2023 Evening of Innovation gala
Along with SAB chair Katerina Politi, PhD, Ms. Conner Ziegler was recognized at this year's gala. Watch a short video shown during the event.

Sharing the patient and caregiver journeys
Ms. Conner Ziegler spoke with SurvivorNet about her lung cancer journey and was featured in an article and video. Her husband, Tom, shared about caregiving with WebMD.
Research leads to new understanding of STING immune pathways
A 2015 LCRF grantee contributed to newly published research showing how an immune pathway called STING, which normally defends against infection and cancer, can decrease the immune response and help cancer spread. Benjamin Izar, MD, PhD collaborated with Samuel Bakhoun, MD, PhD and a team from Memorial Sloan Kettering Cancer Center.
Recent FDA approvals
This month, the FDA approved encorafenib plus binimetinib to treat metastatic nonsmall cell lung cancer with a BRAF V600E mutation. More than 30 lung cancer treatments have received FDA approval in the 2020s alone.
LCMC4 enrolls 100th patient
This week, LCRF announced the enrollment of 100 patients in its 4th study, LCMC4 Evaluation of Actionable Drivers in EaRly Stage Lung Cancer (LEADER), which examimes targeted drugs to specific genetic mutations.
Spanish-language lung cancer information and materials
LCRF announced Know Your Risk: A Hispanic and Latino American’s Guide to Lung Cancer Sept. 20 at the National Hispanic Foundation for the Arts annual gala. The program includes a documentary video, featuring Dr. Narjust Florez and two of her patients, along with PSAs featuring award-winning actor, Esai Morales. An expanded number of patient resources are now available in Spanish as well. A Spanish-language #TogetherSeparately, Vivir con Cancér de Pulmón, took place Sept. 21. Watch the recording here.
Lung Cancer Awareness Month
Every November, people around the world work together to recognize and raise awareness of the challenges that come with a diagnosis of lung cancer. Find out how you can make an impact during #LCAM23.
Doctors to discuss integrative and complementary therapies
Dr. Narjust Florez will join moderator Dr. Isabel Preeshagul on Dec. 6 at 3 PM ET for a #TogetherSeparately webinar focusing on complementary, alternative, and integrative therapies in the treatment of lung cancer. Bring your questions!
Livestream on mindfulness for those facing the holidays after a loss
On Dec 6, LCRF and CancerCare will host a livestream conversation on mindfulness for people who have lost someone. Drop in for casual conversation and share ideas for treating ourselves gently, honor our loved ones, and look toward the future.
Free to Breathe Walk makes memories!
Survivors, caregivers, friends, family, medical staff, and other supporters gathered together and virtually during Free to Breathe Walk weekend Sept. 30 - Oct. 1 to raise awareness and funds for lung cancer research. In-person events were held in Chicago and Kansas City; the Free to Breathe Anywhere Walk had participants from all over the U.S., plus Germany. It's not too late to show your appreciation for a walker with a donation toward research!
Gala celebrates scientific discovery, honors two dedicated women
LCRF's annual Evening of Innovation gala in September celebrated scientific discovery, honored the work of lung cancer luminaries, and raised over $550,000 for lung cancer research that will save lives. Katerina Politi, PhD, received the evening’s Gala Honoree Award; Colleen Conner Ziegler was recognized as LCRF's first Research Advocate Honoree.
Support matters, because 'cancer is hard'
Christine was in disbelief when she found out she had stage 4 lung cancer. "I also immediately thought, okay, I have this – what do we do? What is my game plan? Let's do this."

...our Team LCRF marathoners who are running the Marine Corps Marathon this weekend and the TCS New York City Marathon next weekend.
...Jacob Kaufman, MD, PhD; Jeremy Brownstein, MD; Coral Olazagasti , MD; Estelamari Rodriguez, MD, MPH; Ana Velázquez Mañana, MD, MSc; Jyoti Patel, MD; and Jessica Lin, MD for giving their time and expertise to this quarter's #TogetherSeparately webinars, and as always, Dr. Isabel Preeshagul for moderating!
...our speakers and panel for the 2023 Scientific Symposium, Kathryn O’Donnell, PhD; Brendon M. Stiles, MD; Aaron Hata, MD, PhD; Nikhil Joshi, PhD; Stephen V. Liu, MD; Christine Lovly, MD, PhD; Triparna Sen, PhD; Colleen Conner Ziegler; and chat moderator Isabel Preeshagul, DO, MBS.





LCRF logo

Donate | Unsubscribe | View E-News Online

Lung Cancer Research Foundation, 501 7th Ave, Suite 230, New York, NY 10018 | | ©2022

powered by Blackbaud
nonprofit software